These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11750442)

  • 1. Proteinuria as a useful clinical marker of cyclosporine nephrotoxicity in renal transplant patients.
    Fernández-Fresnedo G; Escallada R; Rodrigo E; Zubimendi JA; de Francisco AL; Herraez I; Arias M
    Transplant Proc; 2001; 33(7-8):3373-4. PubMed ID: 11750442
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent proteinuria as a useful parameter to distinguish between chronic renal rejection and cyclosporin nephrotoxicity.
    Fernández-Fresnedo G; Escallada R; Rodrigo E; Piñera C; de Francisco AL; Ruiz JC; Cotorruelo JG; Zubimendi JA; Arias M
    Transplant Proc; 2002 Feb; 34(1):365-6. PubMed ID: 11959329
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of diagnostic procedures for renal transplant graft function.
    Ozdemir FN; Akçay AT; Ozdemir BH; Turan M; Demirhan B; Colak T; Arat Z; Haberal M
    Transplant Proc; 2002 Sep; 34(6):2096-8. PubMed ID: 12270328
    [No Abstract]   [Full Text] [Related]  

  • 4. Histopathological findings of 10-year protocol biopsy in pediatric kidney transplant recipients.
    Kamimaki I; Shishido S; Ikeda M; Honda M
    Transplant Proc; 2002 Dec; 34(8):3130-1. PubMed ID: 12493397
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine versus tacrolimus in kidney transplantation: are there differences in nephrotoxicity?
    Martins L; Ventura A; Branco A; Carvalho MJ; Henriques AC; Dias L; Sarmento AM; Amil M
    Transplant Proc; 2004 May; 36(4):877-9. PubMed ID: 15194300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index.
    Hortal L; Fernández A; Losada A; Lorenzo M; Baamonde E; Plaza C; Gallego R; Vega N; Palop L
    Transplant Proc; 2001; 33(7-8):3110-1. PubMed ID: 11750337
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of melatonin on renal function in cyclosporine nephrotoxicity.
    Mun KC; Suh SI
    Transplant Proc; 2000 Nov; 32(7):1919-20. PubMed ID: 11120000
    [No Abstract]   [Full Text] [Related]  

  • 8. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A.
    Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M
    Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar?
    Morozumi K; Sugito K; Oda A; Takeuchi O; Fukuda M; Usami T; Oikawa T; Fujinami T; Koyama K; Takeda A; Yoshida A; Haba T; Tominaga Y; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1996 Apr; 28(2):1076-8. PubMed ID: 8623232
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical nephrotoxicity induced by cyclosporin A combined with hormone therapy for nephrotic syndrome.
    Liu X; Li G; Liu X; Huang Y; Xun Z; Song Q; Wang R; Wang C
    Pak J Pharm Sci; 2021 Nov; 34(6(Special)):2441-2445. PubMed ID: 35039257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity.
    Pere AK; Lindgren L; Tuomainen P; Krogerus L; Rauhala P; Laakso J; Karppanen H; Vapaatalo H; Ahonen J; Mervaala EM
    Kidney Int; 2000 Dec; 58(6):2462-72. PubMed ID: 11115079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine does not influence serum cholesterol in kidney transplant recipients.
    Matzkies FK; Keuthage W; Kobelt V; Hillebrand U; Gerhardt U; Suwelack B; Hohage H
    Transplant Proc; 2002 Aug; 34(5):1795-6. PubMed ID: 12176580
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the lower cyclosporine concentration at 2 hours after dosing safe in kidney transplant recipients?
    Einollahi B; Rostami Z; Kalantar E; Lessan-Pezeshki M; Pourfarziani V; Nemati E
    Transplant Proc; 2011 Mar; 43(2):488-90. PubMed ID: 21440741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of subclinical rejection on renal allograft histology and function at 6 months.
    Rush D; Jeffery J; Trpkov K; Solez K; Gough J
    Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.
    Min DI; Perry PJ; Chen HY; Hunsicker LG
    Pharmacotherapy; 1998; 18(2):282-7. PubMed ID: 9545147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricemia and gout in renal transplant recipients.
    Abdelrahman M; Rafi A; Ghacha R; Youmbissi JT; Qayyum T; Karkar A
    Ren Fail; 2002 May; 24(3):361-7. PubMed ID: 12166703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between maintenance dose of cyclosporine and long-term kidney graft survival. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1998 Aug; 30(5):1716-7. PubMed ID: 9723253
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.
    Wilczek HE; Akesson P; Warholm C
    Transplant Proc; 1998 Aug; 30(5):1753-5. PubMed ID: 9723267
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of heavy proteinuria (>1 g/d) following renal transplantation.
    Kim SC; Kang CH; Kim SK; Jang HJ; Kim TH; Jung JG; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1894-5. PubMed ID: 11119989
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.
    Boratyńska M; Banasik M; Watorek E; Falkiewicz K; Patrzałek D; Szyber P; Klinger M
    Transplant Proc; 2006; 38(1):101-4. PubMed ID: 16504675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.